Standard BioTools
LAB
LAB
83 hedge funds and large institutions have $196M invested in Standard BioTools in 2016 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 26 increasing their positions, 27 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
43% less call options, than puts
Call options by funds: $74K | Put options by funds: $130K
56% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 25
Holders
83
Holding in Top 10
–
Calls
$74K
Puts
$130K
Top Buyers
| 1 | +$9.98M | |
| 2 | +$2.03M | |
| 3 | +$1.26M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$1.17M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$822K |
Top Sellers
| 1 | -$15.9M | |
| 2 | -$2.75M | |
| 3 | -$2.31M | |
| 4 |
Lazard Asset Management
New York
|
-$2.26M |
| 5 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
-$1.84M |